Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

JD Health beats expectations — Morgan Stanley praises strong quarter

JD Health reported revenue growth of 29% to about $2.4 billion and a core profit of roughly $170 million, more than double last year. Morgan Stanley says the company clearly beat expectations and confirms the annual guidance of 22% revenue growth, which analysts consider conservative. The stock rose in Hong Kong by more than 6% and is close to breaking the year high of 70.40 HKD; surpassing it could open up further near-term upside to around 90 HKD. » More on deraktionaer.de

Historical dividends Dividends

All dividend metrics All metrics

In 2002, JD HEALTH INTL LTD has already paid €12.14 in dividends. The last payout was in July 2002.

Financials

In the last quarter, JD HEALTH INTL LTD had revenue of €5.2bn and net profit of €437.12m

(EUR)	June 2026	YoY
Revenue	5.2bn	-
Gross profit	1.36bn	-
Net profit	437.12m	-
EBITDA	425.32m	-

Fundamentals

Metric	Value
Market capitalization	€15bn
Number of shares	3.19bn
52-week high/low	€8.29 - €3.68
Dividends	No
Beta	1.22
P/E ratio	18.00
PEG ratio	0.61
P/B ratio	1.79
P/S ratio	1.40

Company profile

JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Name	JD HEALTH INTL LTD
CEO	Dong Cao
Headquarters	Beijing, be Cayman Islands
Website	ir.jdhealth.com/en/index.php
Sector	Health Care
Industry	Health Care Providers & Services
IPO	08/12/2020
Employees	6,018